A relative ordering-based predictor for tamoxifen-treated estrogen receptor-positive breast cancer patients: multi-laboratory cohort validation.
about
A rank-based transcriptional signature for predicting relapse risk of stage II colorectal cancer identified with proper data sources.The influence of cancer tissue sampling on the identification of cancer characteristics.Tamoxifen therapy benefit predictive signature coupled with prognostic signature of post-operative recurrent risk for early stage ER+ breast cancer.Robust transcriptional tumor signatures applicable to both formalin-fixed paraffin-embedded and fresh-frozen samples.Multi-omics landscapes of colorectal cancer subtypes discriminated by an individualized prognostic signature for 5-fluorouracil-based chemotherapy.Critical limitations of prognostic signatures based on risk scores summarized from gene expression levels: a case study for resected stage I non-small-cell lung cancer.
P2860
A relative ordering-based predictor for tamoxifen-treated estrogen receptor-positive breast cancer patients: multi-laboratory cohort validation.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年学术文章
@wuu
2013年学术文章
@zh
2013年学术文章
@zh-cn
2013年学术文章
@zh-hans
2013年学术文章
@zh-my
2013年学术文章
@zh-sg
2013年學術文章
@yue
2013年學術文章
@zh-hant
name
A relative ordering-based pred ...... -laboratory cohort validation.
@en
A relative ordering-based pred ...... -laboratory cohort validation.
@nl
type
label
A relative ordering-based pred ...... -laboratory cohort validation.
@en
A relative ordering-based pred ...... -laboratory cohort validation.
@nl
prefLabel
A relative ordering-based pred ...... -laboratory cohort validation.
@en
A relative ordering-based pred ...... -laboratory cohort validation.
@nl
P2093
P2860
P1476
A relative ordering-based pred ...... -laboratory cohort validation.
@en
P2093
Bailiang Li
Beibei Chen
Chunyang Liu
Pengfei Li
Tongwei Shi
Xianxiao Zhou
Yuannv Zhang
P2860
P2888
P304
P356
10.1007/S10549-013-2767-8
P407
P577
2013-11-20T00:00:00Z